| Authors: |
Giacomini G; Epigenetics & Cell Fate Centre, CNRS/Université Paris Cité, Paris, France., Piquet S; Epigenetics & Cell Fate Centre, CNRS/Université Paris Cité, Paris, France., Chevallier O; Epigenetics & Cell Fate Centre, CNRS/Université Paris Cité, Paris, France., Dabin J; Epigenetics & Cell Fate Centre, CNRS/Université Paris Cité, Paris, France., Bai SK; Epigenetics & Cell Fate Centre, CNRS/Université Paris Cité, Paris, France., Kim B; Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada., Siddaway R; Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada., Raught B; Princess Margaret Cancer Centre, University Health Network, 101 College Street, Toronto, ON M5G1L7, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Canada., Coyaud E; Princess Margaret Cancer Centre, University Health Network, 101 College Street, Toronto, ON M5G1L7, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Canada.; Université de Lille, Inserm, CHU Lille, U1192 - Protéomique Réponse Inflammatoire Spectrométrie de Masse - PRISM, F-59000 Lille, France., Shan CM; Department of Biological Sciences, Columbia University, New York, NY 10027, USA., Reid RJD; Department of Genetics & Development, Columbia University Irving Medical Center, New York, NY 10032, USA., Toda T; Department of Biological Sciences, Columbia University, New York, NY 10027, USA., Rothstein R; Department of Genetics & Development, Columbia University Irving Medical Center, New York, NY 10032, USA.; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032, USA., Barra V; CNRS UMR9019 Genome Integrity and Cancers, Université Paris-Saclay, Gustave Roussy Institute, Villejuif, France., Wilhelm T; CNRS UMR9019 Genome Integrity and Cancers, Université Paris-Saclay, Gustave Roussy Institute, Villejuif, France., Hamadat S; CNRS UMR9019 Genome Integrity and Cancers, Université Paris-Saclay, Gustave Roussy Institute, Villejuif, France., Bertin C; CNRS UMR9019 Genome Integrity and Cancers, Université Paris-Saclay, Gustave Roussy Institute, Villejuif, France., Crane A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA., Dubois F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA., Forne I; Protein Analysis Unit, BioMedical Center, Faculty of Medicine, Ludwig-Maximilians-University, Martinsried, Germany., Imhof A; Protein Analysis Unit, BioMedical Center, Faculty of Medicine, Ludwig-Maximilians-University, Martinsried, Germany., Bandopadhayay P; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, USA., Beroukhim R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA., Naim V; CNRS UMR9019 Genome Integrity and Cancers, Université Paris-Saclay, Gustave Roussy Institute, Villejuif, France., Jia S; Department of Biological Sciences, Columbia University, New York, NY 10027, USA., Hawkins C; Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada., Rondinelli B; Epigenetics & Cell Fate Centre, CNRS/Université Paris Cité, Paris, France., Polo SE; Epigenetics & Cell Fate Centre, CNRS/Université Paris Cité, Paris, France. |
